Viking's $350M of­fer­ing; Bak­er Broth­ers leads an­oth­er PIPE

Plus, news about Ap­plied Ther­a­peu­tics, Beam Ther­a­peu­tics, Janux Ther­a­peu­tics and more:

Viking Ther­a­peu­tics sells off $350M of stock fol­low­ing pos­i­tive obe­si­ty drug da­ta: On the same day that Viking shared pos­i­tive topline da­ta for its “dou­ble G” GLP-1/GIP re­cep­tor ag­o­nist that could com­pete with Eli Lil­ly’s Zep­bound, the com­pa­ny an­nounced a pub­lic of­fer­ing, aim­ing to sell $350 mil­lion of its shares. Viking said it would use the mon­ey to de­vel­op its obe­si­ty drug as well as oth­ers in its pipeline. — Kather­ine Lewin

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER